Cited by 254Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchAmyloidosis: Diagnosis, Treatment, Outcomes

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

ALSFRS-R score and its ratio: A useful predictor for ALS-progression

Kollewe, Katja, Mauss, Ulrike, Krampfl, Klaus, Petri, Susanne, Dengler, Reinhard, Mohammadi, Bahram·2008·Journal of the Neurological Sciences

DOI 10.1016/j.jns.2008.07.016

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. To determine predictors of survival, we studied different parameters in our ALS Database including 479 patients. The effects of individual prognostic factors of survival were studied using Kaplan-Meier life table. The prognostic value of each factor of interest was expressed in terms of a hazard ratio. Survival from symptom-onset ranged from 4 months up to 11.9 years. Gender had no effect on survival in our cohort. However, age, site of onset, forced vital capacity, symptom duration and ALSFRS-R score at the first visit were independent prognostic factors in our population (log-rank p<0.01). The ratio of ALSFRS-R score between first symptom and first examination, during whole disease or within 100 days, correlates with survival time. We conclude that the ratio of ALSFRS-R score within 100 days is a useful parameter for clinical trials and daily clinical work in a tertiary ALS-clinic.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2008.07.016

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,239
El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,171
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V., Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,303
Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival prediction
Haverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 697
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
文治, 木., Fujimura, C., Ishida, S., Nakajima, H., Furutama, D., Uehara, H., Shinoda, K., Sugino, M., & Hanafusa, T. (2006) · Neurology · doi:10.1212/01.wnl.0000194316.91908.8a · Cited by 568
Prognosis in amyotrophic lateral sclerosis: A population-based study
del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G. (2003) · Neurology · doi:10.1212/01.wnl.0000049472.47709.3b · Cited by 469

Flagged first, then by citations

Show all 38 references

Sorted by citations

Items 101–200 of 254

Épidémiologie de la SLA
Soriani, M., & Desnuelle, C. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.04.004 · Cited by 28
Non-invasive ventilation in amyotrophic lateral sclerosis
Vrijsen, B., Testelmans, D., Belge, C., Robberecht, W., Damme, P. V., & Buyse, B. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.745568 · Cited by 28
Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis
Gong, Z., Lv, G.-P., Gao, L.-N., Lü, Y., Guo, J., & Zang, D.-W. (2018) · Neurodegenerative Diseases · doi:10.1159/000488681 · Cited by 28
Comparison of Phenotypic Characteristics and Prognosis Between Black and White Patients in a Tertiary ALS Clinic
Brand, D., Polak, M. A., Glass, J. D., & Fournier, C. N. (2020) · Neurology · doi:10.1212/wnl.0000000000011396 · Cited by 27
Trends of quality of life changes in amyotrophic lateral sclerosis patients
Shamshiri, H., Fatehi, F., Abolfazli, R., Harirchian, M. H., Sedighi, B., Zamani, B., Roudbari, A., Razazian, N., Khamseh, F., & Nafissi, S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.056 · Cited by 26
Cough peak flow decline rate predicts survival in patients with amyotrophic lateral sclerosis
Matsuda, C., Shimizu, T., Nakayama, Y., & Haraguchi, M. (2018) · Muscle & Nerve · doi:10.1002/mus.26320 · Cited by 26
Factors Predicting Survival in ALS Patients - Data from a Population-Based Registry in Rhineland-Palatinate, Germany
Wolf, J., Safer, A., Wöhrle, J. C., Palm, F., Nix, W. A., Maschke, M., & Grau, A. (2015) · Neuroepidemiology · doi:10.1159/000381625 · Cited by 25
Six SQSTM1 mutations in a Chinese amyotrophic lateral sclerosis cohort
Yang, Y., Tang, L., Zhang, N., Pan, L., Hadano, S., & Fan, D. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1009466 · Cited by 24
Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry
Jia, R., Chen, Q. Y., Zhou, Q., Zhang, R., Jin, J., Hu, F., Liu, X., Qin, X., Li, K., Zhao, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00312-8 · Cited by 26
Spastic paraplegia due to recessive or dominant mutations in ERLIN2 can convert to ALS
Amador, M. D. M., Muratet, F., Teyssou, E., Banneau, G., Danel-Brunaud, V., Allart, E., Antoine, J.-C. G., Camdessanché, J., Anheim, M., Rudolf, G., et al. (2019) · Neurology Genetics · doi:10.1212/nxg.0000000000000374 · Cited by 24
Rates of progression of weight and forced vital capacity as relevant measurement to adapt Amyotrophic Lateral Sclerosis management for patient Result of a French multicentre cohort survey
Clavelou, P., Blanquet, M., Peyrol, F., Ouchchane, L., & Gerbaud, L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.06.002 · Cited by 24
Review of disease-modifying drug trials in amyotrophic lateral sclerosis
Tornese, P., Lalli, S., Cocco, A., & Albanese, A. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-328470 · Cited by 23
Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum
Shen, T., Vogel, J. W., Duda, J., Phillips, J. S., Cook, P. A., Gee, J. C., Elman, L. B., Quinn, C. C., Amado, D. A., Baer, M., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00389-3 · Cited by 25
Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis—A Retrospective Cohort Study
Requardt, M. V., Görlich, D., Grehl, T., & Boentert, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081623 · Cited by 22
Cardiac Autonomic Modulation in Subjects with Amyotrophic Lateral Sclerosis (ALS) during an Upper Limb Virtual Reality Task: A Prospective Control Trial
Silveira, A. C., de Moraes, Í. A. P., Vidigal, G. D. P., Simcsik, A. O., Rosa, R. M., Fávero, F. M., Fernandes, S. M. D. S., Garner, D. M., de Araújo, L. V., Massa, M., et al. (2022) · BioMed Research International · doi:10.1155/2022/4439681 · Cited by 23
Association between macronutrient intake and amyotrophic lateral sclerosis prognosis
Kim, B., Jin, Y., Kim, S. H., & Park, Y. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1466459 · Cited by 22
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis
Hodgkinson, V. L., Lounsberry, J., Mirian, A., Genge, A. L., Benstead, T. J., Briemberg, H., Grant, I. M., Hader, W. J., Johnston, W. S. W., Kalra, S., et al. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.311 · Cited by 22
Diaphragm ultrasonography in amyotrophic lateral sclerosis: a diagnostic tool to assess ventilatory dysfunction and disease severity
Sartucci, F., Pelagatti, A., Santin, M., Bocci, T., Dolciotti, C., & Bongioanni, P. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03938-9 · Cited by 22
Disease progression but not physical state per se determines mental wellbeing in ALS
Vázquez, C., Aho-Özhan, H. E. A., Weiland, U., Uttner, I., Ludolph, A. C., & Lulé, D. E. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10027-x · Cited by 22
Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*
Hamidou, B., Marin, B., Lautrette, G., Nicol, M., Camu, W., Corcia, P., Arné‐Bes, M., Tranchant, C., Clavelou, P., Hannequin, D., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1353098 · Cited by 20
Learning dynamic Bayesian networks from time-dependent and time-independent data: Unraveling disease progression in Amyotrophic Lateral Sclerosis
Leão, T., Madeira, S. C., Gromicho, M., de Carvalho, M. A., & Carvalho, A. M. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103730 · Cited by 20
Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study
Chen, X., Wei, Q., Wei, Q., Ou, R., Zhang, L., Yuan, X.-Q., Yao, Y.-Q., Jia, D., Zhang, Q., Li, W.-X., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293159 · Cited by 19
Machine Learning Solutions Applied to Amyotrophic Lateral Sclerosis Prognosis: A Review
Papaiz, F., Júnior, M. E. T. D., Valentim, R. A. D. M., de Morais, A. H. F., & Arrais, J. P. (2022) · Frontiers in Computer Science · doi:10.3389/fcomp.2022.869140 · Cited by 19
Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise
Lanfranconi, F., Ferri, A., Corna, G., Bonazzi, R., Lunetta, C., Silani, V., Riva, N., Rigamonti, A., Maggiani, A., Ferrarese, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02811-z · Cited by 19
Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis
Yu, J., Wang, N., Qi, F., Wang, X., Zhu, Q., Lu, Y., Zhang, H., Che, F., & Li, W. (2018) · Biomedical Reports · doi:10.3892/br.2018.1138 · Cited by 19
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans
Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Collins, D., Averill, J. G., Walker, S. E., Robey, I., Cherry, J. D., Alvarez, V. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12876 · Cited by 20
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis
Lunetta, C., Lizio, A., Gerardi, F., Tarlarini, C., Filippi, M., Riva, N., Tremolizzo, L., Diamanti, S., Dellanoce, C., Mosca, L., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10047-7 · Cited by 19
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection
Blasco, H., Patin, F., Andres, C. R., Corcia, P., & Gordon, P. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1202919 · Cited by 19
Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
Caplliure-Llopis, J., Escrivá, D., Benlloch, M., de la Rubia Ortí, J. E., Estrela, J. M., & Barrios, C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.599216 · Cited by 19
Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study
Carrera‐Juliá, S., Estrela, J. M., Zacarés, M., Navarro, M. Á., Vega‐Bello, M. J., Ortí, J. E. D. L. R., Moreno, M. L., & Drehmer, E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1232184 · Cited by 18
Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data
Karas, M., Olsen, J. M., Strączkiewicz, M., Johnson, S. A., Burke, K. M., Iwasaki, S., Lahav, A., Scheier, Z. A., Clark, A., Iyer, A. S., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52050 · Cited by 18
High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS
Rosén, C., Mitre, B., Nellgård, B., Axelsson, M., Constantinescu, R., Andersen, P. M., Dalla, K., Blennow, K., Nilsson, G., Zetterberg, H., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123112 · Cited by 18
Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review
Brito, M. D., da Silva, G. F. G., Tilieri, E. M., de Araujo, B. P. R., Calió, M. L., & Rosenstock, T. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01205 · Cited by 18
Relationship between Dietary Fiber Intake and the Prognosis of Amytrophic Lateral Sclerosis in Korea
Yu, H., Kim, S. H., Noh, M., Lee, S.-G., & Park, Y. (2020) · Nutrients · doi:10.3390/nu12113420 · Cited by 18
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study
Morales, R. J., Pageot, N., Bendarraz, A., Alphandery, S., Sedel, F., Seigle, S., & Camu, W. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.100254 · Cited by 17
Factors Affecting Energy Metabolism and Prognosis in Patients with Amyotrophic Lateral Sclerosis
Kurihara, M., Bamba, S., Yasuhara, S., Itoh, A., Nagao, T., Nakanishi, N., Nakamura, R., Ogawa, N., Kitamura, A., Yamakawa, I., et al. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000518908 · Cited by 17
Longitudinal comparison of the self‐entry Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised ( ALSFRS‐RSE ) and Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale ( ROADS ) as outcome measures in people with amyotrophic lateral sclerosis
Johnson, S. A., Burke, K. M., Scheier, Z. A., Keegan, M., Clark, A., Chan, J. G. M., Fournier, C. N., & Berry, J. D. (2022) · Muscle & Nerve · doi:10.1002/mus.27691 · Cited by 17
Épidémiologie, spectre clinique de la SLA et diagnostics différentiels
Couratier, P., Marin, B., Lautrette, G., Nicol, M., & Preux, P. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.013 · Cited by 24
Neurophysiological index is associated with the survival of patients with amyotrophic lateral sclerosis
Cao, B., Wei, Q., Ou, R., Zhang, L., Hou, Y., Chen, Y., & Shang, H. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.05.012 · Cited by 16
A nerve conduction study predicts the prognosis of sporadic amyotrophic lateral sclerosis
Imai, E., Nakamura, T., Atsuta, N., Nakatochi, M., Suzuki, M., Harada, Y., Nakamura, R., Hayashi, N., Sobue, G., & Katsuno, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09858-5 · Cited by 15
Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients
Wei, Q., Chen, Y., Chen, X., Cao, B., Ou, R., Zhang, L., Hou, Y., & Shang, H. (2018) · Aging and Disease · doi:10.14336/ad.2017.1016 · Cited by 15
Alterations of Microstructure and Sodium Homeostasis in Fast Amyotrophic Lateral Sclerosis Progressors: A Brain DTI and Sodium MRI Study
Mendili, M. M. E., Grapperon, A., Dintrich, R., Stellmann, J., Ranjeva, J., Guye, M., Verschueren, A., Attarian, S., & Zaaraoui, W. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7559 · Cited by 14
Percutaneous endoscopic gastrostomy with and without jejunal extension in patients with amyotrophic lateral sclerosis
Kirstein, M. M., Körner, S., Schneider, A. S., Manns, M. P., Petri, S., & Voigtländer, T. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001054 · Cited by 14
Self-citation
A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional survey
Boyce, D. M., Robinson, M., Cedarbaum, J. M., Shank, L. M., McDermott, C. J., & van Eijk, R. P. A. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2140592 · Cited by 13
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline
Hamatani, T., Atsuta, N., Sano, F., Nakamura, R., Hayashi, Y., & Sobue, G. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2309989 · Cited by 13
Electrically evoked multiplet discharges are associated with more marked clinical deterioration in motor neuron disease
Sleutjes, B. T. H. M., Maathuis, E. M., van Doorn, P. A., Blok, J. H., & Visser, G. H. (2015) · Muscle & Nerve · doi:10.1002/mus.24700 · Cited by 13
Amyotrophic Lateral Sclerosis in Korea: Clinical Characteristics and Prognostic Factors
백원기, 박아람, Kim, H., & Kim, S. H. (2011) · Journal of the Korean Neurological Association · Cited by 13
Using automated electronic medical record data extraction to model ALS survival and progression
Karanevich, A. G., Weisbrod, L. J., Jawdat, O., Barohn, R. J., Gajewski, B. J., He, J., & Statland, J. (2018) · BMC Neurology · doi:10.1186/s12883-018-1208-z · Cited by 13
Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis
Luna, J., Couratier, P., Lahmadi, S., Lautrette, G., Fontana, A., Tortelli, R., Logroscino, G., Preux, P., Copetti, M., & Marin, B. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1903506 · Cited by 12
Dietary Intake of Micronutrients and Disease Severity in Patients with Amyotrophic Lateral Sclerosis
Barros, A. N. D. A. B., Felipe, M. L. D. N., Barbosa, I. R., Leite-Lais, L., & Pedrosa, L. F. C. (2023) · Metabolites · doi:10.3390/metabo13060696 · Cited by 13
China amyotrophic lateral sclerosis registry of patients with Traditional Chinese Medicine (CARE-TCM): Rationale and design
Song, Y., Li, M., Sugimoto, K., Han, Y. Z., Liu, J., Ma, B., Song, H., Zhang, C., & Gao, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114774 · Cited by 11
An Automated Tongue Tracker for Quantifying Bulbar Function in ALS
Northall, A., Mukhopadhyay, B., Weber, M., Petri, S., Prudlo, J., Vielhaber, S., Schreiber, S., & Kuehn, E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.838191 · Cited by 11
Self-citation
bFGF in the CSF and serum of sALS patients
Gong, Z., Gao, L., Guo, J., Lu, Y., & Zang, D. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12381 · Cited by 11
Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis
Shibuya, K., Misawa, S., Kimura, H., Noto, Y., Sekiguchi, Y., Iwai, Y., Shimizu, T., Mizuno, T., Nakagawa, M., & Kuwabara, S. (2016) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12044 · Cited by 11
Iranian clinical practice guideline for amyotrophic lateral sclerosis
Boostani, R., Olfati, N., Shamshiri, H., Salimi, Z., Fatehi, F., Hedjazi, S. A., Fakharian, A., Ghasemi, M., Okhovat, A. A., Basiri, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1154579 · Cited by 12
Perioperative management of patients with amyotrophic lateral sclerosis: A narrative review
Paul, D., Wright, M., Palmer, J. M., & Russell, T. B. (2022) · Anaesthesia and Intensive Care · doi:10.1177/0310057x211065042 · Cited by 10
Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice
Ludolph, A. C., Corcia, P., Desnuelle, C., Heiman-Patterson, T. D., Mora, J. S., Mansfield, C. D., & Couratier, P. (2024) · Muscle & Nerve · doi:10.1002/mus.28101 · Cited by 10
Transplantation of autologous peripheral blood mononuclear cells in the subarachnoid space for amyotrophic lateral sclerosis: a safety analysis of 14 patients
Liu, J., Li, X., Liang, Z., Han, C., Wei, W., Song, C., Zhou, L., Liu, Y., Li, Y., & Ji, X.-F. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202918 · Cited by 10
Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis – a longitudinal study
Wigand, B., Schlichte, I., Schreiber, S., Heitmann, J., Meyer, T., Dengler, R., Petri, S., Haghikia, A., Vielhaber, S., & Vogt, S. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1962354 · Cited by 10
Self-citation
Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis
Picher‐Martel, V., Boutej, H., Vézina, A., Cordeau, P., Kaneb, H., Julien, J., Genge, A. L., Dupré, N., & Križ, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065065 · Cited by 11
Decremental Responses to Repetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis
Hu, F., Jin, J., Kang, L., Jia, R., Qin, X., Liu, X., Liu, X., Liu, C., Wang, L. Y., Zhang, R., et al. (2018) · European Neurology · doi:10.1159/000494670 · Cited by 10
Mapping of critical events in disease progression through binary classification: Application to amyotrophic lateral sclerosis
Dalgic, O. O., Wu, H., Erenay, F. S., Sır, M. Y., Özaltın, O. Y., Crum, B. A., & Pasupathy, K. S. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103895 · Cited by 13
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial
Gianferrari, G., Costantini, R. C., Crippa, V., Carra, S., Bonetto, V., Pansarasa, O., Cereda, C., Zucchi, E., Martinelli, I., Simonini, C., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae304 · Cited by 10
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient’s smartphone proves to be non-inferior to clinic data capture
Steinfurth, L., Grehl, T., Weyen, U., Kettemann, D., Steinbach, R., Rödiger, A., Großkreutz, J., Petri, S., Boentert, M., Weydt, P., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2468404 · Cited by 8
Self-citation
The impact of spasticity on diaphragm contraction: Electrophysiological assessment
Miranda, B., Pinto, S., & de Carvalho, M. A. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.05.002 · Cited by 8
Tollgate-based progression pathways of ALS patients
Dalgic, O. O., Erenay, F. S., Pasupathy, K. S., Özaltın, O. Y., Crum, B. A., & Sır, M. Y. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09199-y · Cited by 8
Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?
Ortí, J. E. D. L. R., Armero, J. L. P., Sanchis-Sanchis, C. E., Sancho-Castillo, S., Salazar, A., Caplliure‐Llopis, J., Navarro-Illana, E., Barrios, C., Escribá-Alepuz, J., & Benlloch, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081582 · Cited by 8
Relationship between Dietary Total Antioxidant Capacity and the Prognosis of Amyotrophic Lateral Sclerosis
Eom, J., Son, B., Kim, S. H., & Park, Y. (2022) · Nutrients · doi:10.3390/nu14163264 · Cited by 8
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study
Gianferrari, G., Martinelli, I., Simonini, C., Zucchi, E., Fini, N., Caputo, M. D., Ghezzi, A., Gessani, A., Canali, E., Casmiro, M., et al. (2023) · Life · doi:10.3390/life13040942 · Cited by 7
Spread Direction and Prognostic Factors in Limb-Onset Sporadic Amyotrophic Lateral Sclerosis
Hu, F., Jin, J., Jia, R., Li, X., Qi, H., Chen, X., & Dang, J. (2016) · European Neurology · doi:10.1159/000446365 · Cited by 8
Multiparametric Analysis of Sniff Nasal Inspiratory Pressure Test in Middle Stage Amyotrophic Lateral Sclerosis
Sarmento, A., Aliverti, A., Marques, L., Pennati, F., Júnior, M. E. T. D., Fregonezi, G., & Resqueti, V. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00306 · Cited by 8
Coping as a resource to allow for psychosocial adjustment in fatal disease: results from patients with amyotrophic lateral sclerosis
Finsel, J., Rosenbohm, A., Peter, R. S., Bäzner, H., Börtlein, A., Dempewolf, S., Schabet, M., Hecht, M. J., Kohler, A., Opherk, C., et al. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1361767 · Cited by 7
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients
Marchi, F. D., Serioli, M., Collo, A., Belotti, E. G., Alloatti, F., Biroli, G., Bolioli, A., Cantello, R. M., Riso, S., & Mazzini, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154286 · Cited by 7
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment
Marchi, F. D., Saraceno, M., Sarnelli, M. F., Virgilio, E., Cantello, R. M., & Mazzini, L. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06751-7 · Cited by 7
Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression
Karanevich, A. G., Statland, J. M., Gajewski, B. J., & He, J. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0479-9 · Cited by 7
The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study
Hu, N., Shen, D., Yang, X., Cui, L., & Liu, M. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01849-1 · Cited by 7
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis
Marchi, F. D., Mareschi, K., Ferrero, I., Cantello, R. M., Fagioli, F., & Mazzini, L. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.02.005 · Cited by 7
Predicting clinical events characterizing the progression of amyotrophic lateral sclerosis via machine learning approaches using routine visits data: a feasibility study
Guazzo, A., Atzeni, M., Idi, E., Trescato, I., Tavazzi, E., Longato, E., Manera, U., Chiò, A., Gromicho, M., Alves, I., et al. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02719-5 · Cited by 6
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions
Manera, U., D’Ovidio, F., Cabras, S., Torrieri, M. C., Canosa, A., Vasta, R., Palumbo, F., Grassano, M., Marchi, F. D., Mazzini, L., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15674 · Cited by 6
Association between dietary patterns and the prognosis of amyotrophic lateral sclerosis in China: a cross-sectional study
Xu, X., Huang, Y., Zhu, Y., & Jin, Q. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1437521 · Cited by 5
Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: a proteomic study
Nakamura, K., Fujita, K., Suzuki, M., Kunugi, A., Hirozane, Y., Kunikata, T., Takahashi, B., Narazaki, G., Kondo, H., Haji, S., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1418320 · Cited by 5
Enhanced Acute Muscle Activation in ALS Patients Following Liposomal Curcumin, Resveratrol, and Dutasteride Administration
Martín-Ruiz, J., Maset-Roig, R., Caplliure‐Llopis, J., Villarón-Casales, C., Alarcón-Jiménez, J., de Bernardo, N., Proaño, B., Menargues-Ramírez, R., Selvi-Sabater, P., & Ortí, J. E. D. L. R. (2025) · Pharmaceuticals · doi:10.3390/ph18040497 · Cited by 6
Integrative biomarker discovery in neurodegenerative diseases
Carreiro, A. V., de Mendonça, A., de Carvalho, M. A., & Madeira, S. C. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1310 · Cited by 5
Prodromal muscle cramps predict rapid motor functional decline in amyotrophic lateral sclerosis
Shibuya, K., Misawa, S., Sekiguchi, Y., Beppu, M., Amino, H., Suichi, T., Suzuki, Y.-I., Tsuneyama, A., & Kuwabara, S. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318446 · Cited by 5
A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items
Wicks, P. J., McCaffrey, S. A., Goodwin, K., Black, R. A., Hoole, M., & Heywood, J. (2018) · Journal of Medical Internet Research · doi:10.2196/12075 · Cited by 5
Estimating acceleration time point of respiratory decline in ALS patients: A novel metric
Sato, K., Iwata, A., Kurihara, M., Nagashima, Y., Mano, T., & Toda, T. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.031 · Cited by 5
Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis
Hu, N., Shen, D., Yang, X., Cui, L., & Liu, M. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.01.016 · Cited by 5
Impaired neuromuscular transmission in facial muscles of amyotrophic lateral sclerosis: A single‐fiber electromyography study
Watanabe, K., Shibuya, K., Misawa, S., Nagashima, K., Suzuki, Y., Suichi, T., Kojima, Y., Nakamura, K., Kano, H., Prado, M. B., et al. (2022) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12580 · Cited by 5
Amyotrophic Lateral Sclerosis–Bulbar Dysfunction Index–Remote: Test–Retest and Interrater Reliability of Candidate Items
Bouvier, L., Green, J. R., Tapia, C. B., Tilton-Bolowsky, V. E., Maffei, M. F., Fless, Z., Seaver, K., Huynh, A., Gutz, S. E., Martino, R., et al. (2023) · American Journal of Speech-Language Pathology · doi:10.1044/2023_ajslp-22-00177 · Cited by 4
Correlation of single-fiber electromyography studies and functional status in patients with amyotrophic lateral sclerosis
Rostás, R., Fekete, I., Horváth, L., Márton, S., & Fekete, K. (2024) · Open Medicine · doi:10.1515/med-2024-0990 · Cited by 4
Ketogenic effect of coconut oil in ALS patients
Carrera‐Juliá, S., Obrador, E., López‐Blanch, R., Oriol‐Caballo, M., Moreno-Murciano, P., & Estrela, J. M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1429498 · Cited by 4
Profiles of disease progression and predictors of mortality in Colombian patients with amyotrophic lateral sclerosis: a comprehensive longitudinal study
Ortiz‐Corredor, F., Correa‐Arrieta, C., Diaz, J. J. F., Castellar-Leones, S. M., & Gil‐Salcedo, A. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2405587 · Cited by 4
Nutritional, Clinical and Sociodemographic Profiles of Spanish Patients with Amyotrophic Lateral Sclerosis
Carrera‐Juliá, S., Estrela, J. M., Zacarés, M., Navarro, M. Á., Vega‐Bello, M. J., Ortí, J. E. D. L. R., Moreno, M. L., & Drehmer, E. (2024) · Nutrients · doi:10.3390/nu16030350 · Cited by 4
Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data
Cai, R., Yang, J., Wu, L., Liu, Y., Wang, X., Zheng, Q., & Li, L. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03057-5 · Cited by 4
Measuring the validation of assessing the non-dominant-hand function by ALSFRS-r in Chinese ALS patients
Hu, F., Jin, J., Jia, R., Li, X., Qi, H., Zhao, X. Q., & Dang, J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.08.036 · Cited by 4
Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland
Kobayter, L., & Chetty, S. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1817-y · Cited by 4
Anesthetic management of a parturient with amyotrophic lateral sclerosis undergoing cesarean section
Li, J., Zeng, H., Li, M., & Wang, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000809 · Cited by 4
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysis
Berry, J. D., Hagan, M., Zhang, J., Liu, Y., & Ciepielewska, M. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2024-0007 · Cited by 3
Shared prognostic information in amyotrophic lateral sclerosis – systematic assessment of the patients’ perception of neurofilament light chain and the ALS functional rating scale
Möhwald, L. M., Maier, A., Grehl, T., Weyen, U., Weydt, P., Günther, R., Lingor, P., Göricke, B., Petri, S., Großkreutz, J., et al. (2025) · Neurological Research and Practice · doi:10.1186/s42466-024-00363-y · Cited by 4
Self-citation
The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial
Oki, R., Izumi, Y., Nodera, H., Sato, Y., Nokihara, H., Kanai, K., Sonoo, M., Urushitani, M., Nishinaka, K., Atsuta, N., et al. (2018) · JMIR Research Protocols · doi:10.2196/12046 · Cited by 3

Authors: Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B.
Affiliations: Medizinische Hochschule Hannover (DE)
Corresponding author: Mohammadi, Bahram
ORCID: Petri, Susanne
Dengler, Reinhard
Mohammadi, Bahram
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 2008-12
Volume: 275
Issue: 1-2
Pages: 69-73
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/j.jns.2008.07.016
OpenAlex: W2026980091
Cited by: 253
References: 38
Citations by year: 2026: 8 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 21 · 2021: 13 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 19 · 2015: 23 · 2014: 15 · 2013: 7 · 2012: 11
FWCI: 3.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords: amyotrophic lateral sclerosis, ALSFRS-R, disease progression, survival prediction, prognostic factors, symptom onset, age, forced vital capacity, symptom duration, hazard ratio
MeSH terms: Adult, Age Factors, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Severity of Illness Index, Cohort Studies, Age of Onset, Disease Progression, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALSFRS-R score and its ratio: A useful predictor for ALS-progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks